Conisus
Conisus is an Atlanta-based medical communications holding company serving biopharmaceutical companies with brand strategy, KOL management, and launch support. It operates four wholly-owned sister agencies focused on oncology, hematology, international execution, and rare diseases, plus the ASTOUND SaaS business intelligence platform for KOL data.
- Company typePrivate
- Founded1999
- HeadquartersAtlanta, United States
- Headcount51–100
- GTM typeB2B
- OfferingServices
What Conisus does
Conisus (Conisus, LLC) is a privately held, Atlanta-based holding company that, through four wholly-owned subsidiary agencies—Envision Communications, E Squared Communications, S Phase, and Vereo Communications—provides strategic medical communications and brand intelligence services to biopharmaceutical clients. Founded in 1999 (firmographic records also reference 1995) and operating with 51–100 employees, the company is vertically specialized in oncology and hematology, with a secondary focus on rare diseases and specialty therapeutics via Vereo. Service offerings include messaging platform development, KOL identification and mapping, business intelligence, brand-planning, and pre-launch/launch/post-launch medical education programs for healthcare professionals.
The underlying technology stack centers on the proprietary ASTOUND Business Intelligence Platform, developed by subsidiary S Phase. ASTOUND is a customized, cloud-based SaaS solution that centralizes KOL demographic data, competitive intelligence, affiliation mapping, and activity heat maps, and is offered to biopharma clients for optimizing key opinion leader engagement. The four sister-agency structure provides complementary capabilities: Envision handles oncology/hematology strategy, E Squared executes US and international initiatives, S Phase provides data analytics, and Vereo addresses rare diseases and specialty therapeutics.
Conisus operates a professional-services revenue model with project-by-project quoting rather than disclosed subscription or seat-based pricing. Its go-to-market is enterprise field sales into biopharmaceutical companies, targeting marketing directors, global medical directors, and product managers. Customers are concentrated in two segments—biopharmaceutical companies in oncology/hematology (primary) and rare diseases/specialty therapeutics (secondary)—and engagements typically span multi-quarter strategic planning and launch execution. The company is privately held with no disclosed institutional equity investors or external private equity backing, and the ownership profile is consistent with a founder-led boutique model.
Conisus firmographics
Firmographics- Name
- Conisus
- Legal name
- Conisus, LLC
- Website
- https://conisus.com
- Company type
- Private
- Founded year
- 1999
- Operating status
- Operating
- Headcount range
- 51–100 employees
- Short description
- Conisus is an Atlanta-based medical communications holding company serving biopharmaceutical companies with brand strategy, KOL management, and launch support. It operates four wholly-owned sister agencies focused on oncology, hematology, international execution, and rare diseases, plus the ASTOUND SaaS business intelligence platform for KOL data.
- Ownership category
- akta.pro rank
Conisus industry classification
Industry- Product category
- Medical Communications Services
- NAICS
- Other Scientific and Technical Consulting Services (54169), Custom Computer Programming Services (541511)
- SIC
- Services-Management Services (8741), Services-Computer Programming, Data Processing, Etc. (7370)
- akta.pro primary industry
- Medical Affairs, Scientific Communications & HEOR FSP (HLAGAOAG)
Keywords
Where Conisus is headquartered
LocationHeadquarters
- HQ city
- Atlanta
- HQ country
- United States
- HQ region
- North America
Offices1 record
Markets served
Conisus business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Personnel, Operations, Marketing or Sales, Technology or R&D, Infrastructure
Revenue model
- Strategic Medical Communications Services: Conisus generates revenue through providing strategic medical communication services to biopharmaceutical companies, including brand strategy, business intelligence, educational programs, and consulting services focused on oncology and hematology therapeutic areas.
Go-to-market motion1 record
Distribution channels1 record
Marketing channels3 records
Conisus product offering
Product offeringCore offering
Conisus provides strategic medical communication services to biopharmaceutical companies, focused on oncology, hematology, rare diseases, and specialty therapeutics. Offerings include brand strategy, messaging platform development, KOL identification and management, business intelligence, and pre-launch/launch/post-launch educational planning. Service delivery is supported by a proprietary cloud-based business intelligence platform (ASTOUND) developed by its S Phase subsidiary.
Product overview
Conisus is a medical communications agency providing strategic services to the biopharmaceutical industry through a family of companies. The core offering consists of Conisus (parent company) alongside sister companies Envision Communications, E Squared Communications, S Phase, and Vereo, which collectively provide brand strategy, business intelligence, and customized educational programs focused on oncology/hematology and rare diseases. Specific service offerings include Messaging Platform Development, Business Intelligence Solutions, KOL Management, and New Drug/Company Launch Services. The S Phase brand provides the ASTOUND Business Intelligence Platform for data analytics and KOL management.
Differentiator
Problem solved
Functional benefit
Brands
- Envision Communications: Strategic partners for biopharmaceutical clients focused in oncology/hematology
- E Squared Communications
- S Phase
- Vereo
Products and services
- Strategic Medical Communications Services End-to-end strategic medical communication services for biopharmaceutical clients in oncology, hematology, rare diseases, and specialty therapeutics, including brand strategy, advisory board management, steering committee execution, and customized medical education programs for healthcare professionals.
- Messaging Platform Development
- Business Intelligence and KOL Management Services Pre-launch identification, classification, and mapping of KOLs, regional physicians, community/local practitioners, advocates, and experts, combined with competitive intelligence and activity heat maps to optimize launch initiatives and engagement strategies.
- New Drug and Company Launch Services
- ASTOUND Business Intelligence Platform
Companies that use Conisus
Customer profileNamed customers2 records
Segments2 records
Ideal customer profiles2 records
Conisus technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature1 record
Conisus partnerships and signals
Strategic signalPartnerships
Four partnerships are on record, tiered core.
- Envision CommunicationscoreA global communications company within the Conisus family with extensive experience managing US and international initiatives for biopharmaceutical clients. Operates as a strategic partner providing medical communications services.
- E Squared CommunicationscoreA global communications company within the Conisus family with extensive experience managing US and international initiatives for biopharmaceutical clients. Operates as a strategic partner providing medical communications services.
- S PhasecoreProvides brand strategy, business intelligence, and data analytical services for biopharma companies. Developed the proprietary ASTOUND Business Intelligence Platform used for KOL management solutions. Operates as a strategic partner within the Conisus family.
- Vereo CommunicationscoreStrategic partner for biopharmaceutical clients focused on rare diseases and specialty therapeutics. Provides specialized medical communications services within the Conisus family network.
Scale indicators1 record
Recent moves6 records
Expansion highlights5 records
Conisus competitors and assessment
Company assessmentDirect peers
- ApotheCom: ApotheCom is a medical communications agency serving biopharmaceutical clients with strategic and scientific communications, directly comparable to Conisus's core offering. Both serve biopharma with KOL engagement and medical education services.
- Peloton Advantage: Peloton Advantage is a medical communications and publications planning agency serving pharma/biotech, closely comparable to Conisus's oncology-focused scientific communications and brand strategy offerings.
- Cello Health (now Cello Health Group / acquired by PharmaLex): Cello Health provides strategic medical communications, market research, and KOL services to biopharma clients, directly comparable to Conisus's brand strategy, business intelligence, and medical education offerings.
- MedThink Communications: MedThink Communications is a medical communications agency specializing in healthcare provider and patient education programs for pharma clients, with comparable service overlap to Conisus's medical education focus.
- Fishawack Health: Fishawack Health is a specialist medical communications and consulting group serving biopharma with scientific communications and brand strategy. Highly comparable to Conisus in service model, though typically larger and broader in therapeutic coverage.
Broad incumbents
- Syneos Health Communications: Syneos Health offers broad biopharmaceutical services including medical communications and KOL management as part of a much larger CRO/services portfolio. While not oncology-specialized like Conisus, it competes for biopharma medical communications mandates at scale.
- Inizio (Ashfield Health): Inizio's Ashfield Health division offers global medical communications, advisory, and KOL engagement services to biopharma. As a much larger global player, it competes with Conisus for enterprise MedComms engagements.
- Ogilvy Health: Ogilvy Health is a large global health communications agency offering medical education, brand strategy, and KOL programs to biopharma clients. As a broad incumbent, it competes with Conisus especially for large multi-indication programs.
- Havas Health & You: Havas Health & You is a major global health communications network offering medical communications, brand strategy, and KOL services. Comparable to Conisus in capability set, though operating at much larger scale across many therapeutic areas.
- Sudler & Hennessey: Sudler (part of WPP) is a global healthcare communications network offering brand strategy, KOL engagement, and medical education to biopharma. As a broad incumbent with global reach, it competes with Conisus for enterprise biopharma engagements.
Market position
Strengths5 records
Weaknesses4 records
Competitive moat5 records
Key risks6 records
Key highlights6 records
Customer concentration
Conisus social profiles
Digital presenceConisus financial estimates
Financial estimateRevenue estimate
Valuation estimate
Conisus leadership team
Management profileNumber of profiles
Profiles2 records
Conisus subsidiaries and ownership
Company hierarchySubsidiaries4 records
Conisus funding detail
Funding detailFunding overview
Funding rounds2 records
Investors2 records
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Conisus M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Conisus
What does Conisus do?
Conisus provides strategic medical communication services to biopharmaceutical companies, focused on oncology, hematology, rare diseases, and specialty therapeutics. Offerings include brand strategy, messaging platform development, KOL identification and management, business intelligence, and pre-launch/launch/post-launch educational planning. Service delivery is supported by a proprietary cloud-based business intelligence platform (ASTOUND) developed by its S Phase subsidiary.
Is Conisus a public or private company?
Conisus is a private company. It is classified as founder individual operated bootstrapped and is currently operating.
When was Conisus founded?
Conisus was founded in 1999. It employs 51 to 100 people.
Where is Conisus based?
Conisus is headquartered in Atlanta, United States, in the North America region.
How does Conisus make money?
One revenue line is on record: strategic Medical Communications Services.
Who are Conisus's main competitors?
Direct peers on record are ApotheCom, Peloton Advantage, Cello Health (now Cello Health Group / acquired by PharmaLex), MedThink Communications and Fishawack Health. Broad incumbents are Syneos Health Communications, Inizio (Ashfield Health), Ogilvy Health, Havas Health & You and Sudler & Hennessey.
Does Conisus have an API?
No public API is recorded for Conisus.
What industry is Conisus in?
Conisus's product category is Medical Communications Services. Its primary akta.pro industry code is HLAGAOAG, Medical Affairs, Scientific Communications & HEOR FSP. Its NAICS code is 54169 and its SIC code is 8741.